{
    "id": "0173",
    "question": "A 26-year-old woman comes to the physician because of fatigue, weight loss, and muscle aches during the past 2 months. There is no personal or family history of serious illness. Her only medication is a multivitamin. A metyrapone stimulation test is performed and the results rule out a diagnosis of adrenal insufficiency. Which of the following changes in laboratory findings are most likely to have been observed in this patient following the administration of the drug?",
    "options": {
        "A": "Increase in serum ACTH",
        "B": "Decrease in urinary 17-hydroxycorticosteroids",
        "C": "Decrease in serum 11-deoxycortisol",
        "D": "Increase in serum cortisol"
    },
    "answer": "A",
    "predict": "To approach this question, let's break it down step by step: 1. **Patient's symptoms**: The patient presents with fatigue, weight loss, and muscle aches. These symptoms are non-specific but can be associated with various endocrine disorders, including adrenal insufficiency. 2. **Metyrapone stimulation test**: The metyrapone stimulation test is used to assess the body's ability to produce cortisol. Metyrapone is a medication that inhibits the enzyme 11-beta hydroxylase, which is involved in the production of cortisol. By administering metyrapone, the body's natural response to the lack of cortisol production is observed. 3. **Ruling out adrenal insufficiency**: The metyrapone stimulation test results rule out a diagnosis of adrenal insufficiency. This means that the patient's body is able to produce cortisol in response to the metyrapone test, indicating that the adrenal glands are functioning normally. 4. **Understanding cortisol production**: Cortisol is a steroid hormone produced by the adrenal glands. It plays a crucial role in regulating blood sugar levels, blood pressure, and the body's response to stress. The production of cortisol involves several steps, including the conversion of 11-deoxycortisol to cortisol. 5. **Analyzing the options**: - A. Increase in serum ACTH (Adrenocorticotropic hormone): ACTH stimulates the adrenal glands to produce cortisol. If the adrenal glands are not responding to the metyrapone test, it's unlikely that ACTH levels would increase. - B. Decrease in urinary 17-hydroxycorticosteroids: 17-hydroxycorticosteroids are metabolites of cortisol. A decrease in urinary 17-hydroxycorticosteroids would indicate decreased cortisol production, which is not consistent with the metyrapone test results. - C. Decrease in serum 11-deoxycortisol: 11-deoxycortisol is a precursor to cortisol. If cortisol production is normal, the levels of 11-deoxycortisol would likely increase, not decrease. - D. Increase in serum cortisol: Given that the metyrapone test results rule out adrenal insufficiency, it's likely that the patient's cortisol levels are normal. Cortisol levels would not increase in response to the metyrapone test, as the body is able to produce cortisol normally. **Conclusion**: Given the above analysis, the most likely laboratory finding in this patient following the administration of the metyrapone test is a decrease in serum 11-deoxycortisol, as the body is able to produce cortisol normally. ```json { \"step_by_step_thinking\": \"The patient presents with fatigue, weight loss, and muscle aches. The metyrapone stimulation test results rule out a diagnosis of adrenal insufficiency. Cortisol production is normal, so the body would not produce more cortisol in response to metyrapone, and therefore, the levels of 11-deoxycortisol would decrease.\", \"answer_choice\": \"C\" } ```",
    "snippets": [],
    "scores": [],
    "execution_time": 53.513936281204224
}